Navigation Links
Sutro Biopharma Receives the Pantheon 2015 DiNA Outstanding Partner Award by the California Life Sciences Association
Date:11/18/2015

SAN FRANCISCO, Nov. 18, 2015 /PRNewswire/ -- Sutro Biopharma today announced that it was awarded the Outstanding Partner Award, at the California Life Sciences Association (CLSA) annual Pantheon Ceremony 2015 Presenting DiNA Awards.  Late last year, Sutro entered into a broad strategic collaboration and option agreement with Celgene Corporation to discover and develop multi-specific antibodies and antibody drug conjugates (ADCs) in the field of immuno-oncology.  In addition, Sutro entered a multi-target strategic collaboration with EMD Serono (Merck KGaA) to discover and develop antibody drug conjugates (ADCs).  Sutro's cell-free biologics development platforms, Xpress CF and Xpress CF+ are key elements to its strategic collaborations, driving forward the development of next generation immuno-oncology therapeutics. The CLSA has recognized Northern California based Sutro, for its life science achievements throughout the year.

William Newell, chief executive officer of Sutro Biopharma, said, "We are honored to pioneer a new generation of cancer therapeutics with our partners Celgene and EMD Serono. This award recognizes our partnerships as first-rate collaborations designed to achieve the best for patients and health care providers. Our platform and product development efforts bear enormous promise.  These collaborations have worked to accelerate the development of oncology therapeutics, with compelling patient benefit."

About Sutro Biopharma

Sutro Biopharma, Inc., located in South San Francisco, develops best-in-class antibody drug conjugate and multi-specific antibody-based therapeutics for cancer therapy, including Immuno-Oncology therapies. Sutro's discovery and development efforts are driven by our proprietary Xpress CF™ and Xpress CF+™ platforms, a biochemical synthesis system that enables rapid and systematic evaluation of protein structure-activity relationships, as well as rapid and predictable scalability for manufacturing in Sutro's cGMP facility. In addition to developing its own drug candidate pipeline, which is focused on mono- and bi-specific ADCs, Sutro Biopharma is collaborating with select pharmaceutical and biotech companies to discover and develop novel therapeutics.

Media Contacts:

David Schull or Christopher Hippolyte
Russo Partners
(212) 845-4271
(646)942-5634
david.schull@russopartnersllc.com 
chris.hippolyte@russopartnersllc.com


'/>"/>
SOURCE Sutro Biopharma
Copyright©2015 PR Newswire.
All rights reserved


Related biology technology :

1. Sutro Biopharma to Collaborate with University of California, San Francisco (UCSF), a Recombinant Antibody Network (RAN) Member
2. Keryx Biopharmaceuticals to Present at the 25th Annual ROTH Conference
3. New Opportunity: The Biomedical Innovations of Tomorrow - Research Report on PhotoMedex, Axiall Corp, Varian Medical Systems, Volcano Corporation and Navidea Biopharmaceuticals
4. Infinata Implements “Clear Quality” Initiative to Optimize Reliability and Usability of Data, Reports and Analysis for Biopharma and Wealth Management Solutions
5. Verified Clinical Trials (VCT) Will Co-Present With SAFE-BioPharma At Bio-IT World April 10th In Boston, MA Exploring Identity Management In eClinical Trials
6. DSM announces June opening of new cGMP biopharmaceutical manufacturing operation in Brisbane, Australia
7. Biotechnology Market (Biopharmacy, Bioservices, Bioagri, Bioindustrial) Is Expected to Reach USD 414.5 Billion Globally in 2017: Transparency Market Research
8. MannKind, Ariad Pharma, Ziopharm Oncology, Galena Biopharma, and Novavax Under StockCalls Microscope
9. Genedata Biologics for Biopharma R&D at Ninth Annual PEGS
10. PDL BioPharma Appoints Peter Garcia as Chief Financial Officer
11. Array BioPharma to Present at the Bank of America Merrill Lynch Healthcare Conference and the UBS Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/15/2018)... SAN FRANCISCO (PRWEB) , ... November 14, 2018 ... ... Indiegogo campaign, bringing the world’s first self-learning snore-reduction mask to the public. It ... to a poorer quality of sleep for themselves and their partner. The resulting ...
(Date:11/13/2018)... ... 13, 2018 , ... , Park Systems, world leader in Atomic Force Microscopes ... demand for AFM technology in China, Park Systems has decided to provide direct support ... Beijing equipped with Park AFM. , The Grand Opening of the Park Beijing Office ...
(Date:11/9/2018)... ... November 08, 2018 , ... Superior Controls, Inc. , ... with 140 employees on both the east and west coasts, today announced the ... Center on November 14 and 15 in Philadelphia. The event is hosted by ...
(Date:11/5/2018)... ... November 05, 2018 , ... USARAD Holdings Inc., the ... and several healthcare VC firms announces at Distributed Health 2018 conference November 5-6 ... purchasing tokens and obtaining its first radiology interpretations, one of the first known ...
Breaking Biology Technology:
(Date:11/27/2018)... ... 2018 , ... Veni Vici, or Anthony, is a competitive Hunter-Jumper owned by Lisa Companioni Smith. ... time, he was fourteen years old and Lisa was told he would never jump again ... trail horse. Devasted, Lisa sought the expert opinion of veterinarian and surgeon, Dr. Ruth-Anne ...
(Date:11/20/2018)... ... November 19, 2018 , ... SF Bay Cosmetic ... the first and only non-invasive buttock lift procedure, with no injections necessary! Utilizing ... tone and firm the buttocks to provide a safe and completely non-invasive alternative ...
(Date:11/16/2018)... ... November 16, 2018 , ... ... called All Things Chemical™ and it will engage listeners in intelligent, insightful conversation ... business issues surrounding chemicals. B&C’s talented team of lawyers, scientists, and consultants will ...
Breaking Biology News(10 mins):